Nestle(US:NSRGY) Chang Jiang Shang Bao·2026-01-11 23:33Core Viewpoint - Nestlé is conducting a global recall of certain infant formula products due to potential contamination with Bacillus cereus, a bacteria that can cause foodborne illness, affecting multiple countries including China [4][5]. Group 1: Recall Details - On January 6, Nestlé China announced a voluntary recall of 71 batches of infant formula, including 41 batches imported from Europe and 30 batches sold in mainland China [1][6]. - The recalled products include various brands such as "Nestlé BEBA Supreme" and "Wyeth启赋未来" [1][6]. - The recall is a precautionary measure, and as of now, no adverse health reports related to the products have been received [2][5]. Group 2: Market Impact and Performance - Nestlé's sales in the Greater China region have seen a decline, with an organic growth rate of -6.1% for the first three quarters of 2025, and -10.4% in the third quarter [3][8]. - The company is shifting its strategy from a "channel-driven" model to a "demand-driven" approach, as stated by the new CEO, Mark Schneider [3][8]. - From 2019 to 2024, sales in the Greater China region dropped from 6.913 billion Swiss francs to 5.558 billion Swiss francs, with only one year of positive growth [8]. Group 3: Strategic Changes - The new CEO has emphasized the need to address previous sales strategies that relied heavily on channel expansion and inventory pressure, which led to unsustainable practices [8]. - Recent management changes have been made to improve operations, including the appointment of a new head for the dairy business to oversee e-commerce and retail channels [8]. - The company remains committed to long-term development in China, focusing on local innovation and quality products for consumers [9].